MedTrace Logo

Study Protocol for Rosiglitazone Versus Gliclazide in Diabetics With Angina

NCT00225342 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2006-09-08

No results posted yet for this study

Summary

The principle objective of the trial is to compare rosiglitazone to gliclazide in patients with type 2 diabetes mellitus and chronic stable angina to see how the subjects' angina status changes.

Angina status will be measured via exercise tolerance testing, 24-hour ECG testing and angina quality of life questionnaire.

Conditions

  • Angina Pectoris
  • Diabetes Mellitus, Type 2

Interventions

DRUG

Rosiglitazone

DRUG

Gliclazide (Comparison drug)

Sponsors & Collaborators

Principal Investigators

  • Naveed Sattar, MBChB PhD · University of Glasgow

  • Stuart M Cobbe, MBChB MD · University of Glasgow

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00225342 on ClinicalTrials.gov